Frontlight ResearchEarly access
Acute lymphoblastic leukaemia trials in United States
197 of 232 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymph...
- Where
- Atlanta, Bethesda, Boston, Los Angeles, Salt Lake City, Seattle, Washington D.C.
- Age
- 1 year to 25 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05621291 - Phase 1Taking peopleA Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Where
- Atlanta, Aurora, Chicago, Cincinnati, Los Angeles, Palo Alto, Philadelphia, Salt Lake City, San Antonio, Seattle
- Age
- 0 years to 18 years
- People
- 30 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT06173518 · EU 2023-506307-26-00 - Phase 1/2Taking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Chicago, Duarte, Franklin, Houston, Iowa City, Jacksonville
- Age
- 12 years and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - Phase 1Taking peopleAnti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 57
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07572136 - Phase 1Taking peopleGenetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma
- Where
- Duarte, Irvine
- Age
- 18 years and over
- People
- 16
- Run by
- City of Hope Medical Center
See details and how to joinNCT07758673 - Phase 1Not yet taking people in United StatesMetabolically Fit CD19 CAR T Cells With CD34 Selection Markers in Adults With CD19-Positive B-Cell Acute Lymphocytic Leukemia
- Where
- Charleston
- Age
- 18 years and over
- People
- 18
- Run by
- Medical University of South Carolina
See details and how to joinNCT07896213 - Phase 1Taking peopleAsciminib and Inotuzumab Ozogamicin for Relapsed or Refractory Philadelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (R/R Ph+ B-ALL)
- Where
- Chicago, Miami, New York, Seattle
- Age
- 18 years and over
- People
- 45
- Run by
- Sunil G. Iyer
See details and how to joinNCT07936266 - Phase 2Taking peopleInotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- Where
- Aberdeen, Allentown, Alton, Anchorage, Ankeny, Ann Arbor, Arroyo Grande, Atlanta, Ballwin, Baltimore, Bellevue, Bellingham, Bend, Bethlehem, Birmingham, Bloomington, Boise, Bolivar, Branson, Brighton, Buffalo, Burbank, Burr Ridge, Canton, Cape Girardeau, Carbondale, Caro, Carson City, Carterville, Carthage, Centralia, Chadds Ford, Chapel Hill, Chelsea, Chicago, Cincinnati, City of Saint Peters, Clackamas, Clarkston, Clive, Clovis, Columbus, Coos Bay, Creve Coeur, Decatur, Des Moines, Detroit, Dixon, Duarte, Durham, East China Township, East Stroudsburg, Eau Claire, Edmonds, Effingham, Eureka, Evanston, Everett, Farmington, Flint, Fort Lauderdale, Fort Smith, Fruitland, Galesburg, Garden City, Glenview, Great Bend, Greenville, Grosse Pointe Woods, Hazleton, Henderson, Highland Park, Homer Glen, Irvine, Issaquah, Jefferson City, Joplin, Jupiter, Kansas City, Kennewick, Kewanee, Kingman, Lacey, La Jolla, Lake Forest, Lake Success, Lansing, Las Vegas, Lewes, Livonia, Longview, Macomb, Madison, Manhasset, Marlette, Marshfield, Maywood, Melrose Park, Menomonee Falls, Meridian, Millville, Milwaukee, Minocqua, Missoula, Morgantown, Mount Vernon, Nampa, Newark, Newberg, New Berlin, New Hyde Park, New Lenox, New Orleans, New York, Oak Creek, O'Fallon, Oklahoma City, Omaha, Orange, Oregon City, Orland Park, Ottawa, Pahrump, Palo Alto, Pekin, Peoria, Peru, Philadelphia, Pontiac, Portland, Princeton, Redmond, Rehoboth Beach, Reno, Renton, Rice Lake, Richmond, Rochester, Rochester Hills, Rolla, Saginaw, Sainte Genevieve, Saint Joseph, Seaford, Seattle, Sedro-Woolley, Shelton, Springfield, Sterling Heights, Stevens Point, St Louis, Stony Brook, Sullivan, Tawas City, Twin Falls, Vancouver, Walla Walla, Warren, Washington, Washington D.C., Waukee, West Bend, West Branch, West Chester, Weston, Westwood, Wilmington, Winston-Salem, Yakima, Yelm, Ypsilanti
- Age
- 18 years and over
- People
- 84 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03739814 - Phase 1Taking peopleTesting the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Where
- Atlanta, Basking Ridge, City of Saint Peters, Columbus, Commack, Creve Coeur, Harrison, Middletown, Mineola, Montvale, New York, Richmond, St Louis, Uniondale
- Age
- 18 years and over
- People
- 30
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04301076 - Phase 2Taking peopleA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Akron, Albany, Albuquerque, Allentown, Anaheim, Anchorage, Ann Arbor, Arroyo Grande, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bellevue, Bellflower, Bethesda, Birmingham, Boise, Boston, Bridgeport, Brooklyn, Burlington, Carson City, Chapel Hill, Charleston, Charlotte, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Dearborn, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, El Paso, Falls Church, Fargo, Fontana, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Martinsburg, Maywood, Mesa, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Newark, New Brunswick, New Hyde Park, New Orleans, New York, Niles, Norfolk, Norton Shores, Oakland, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Parkersburg, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Providence, Reed City, Reno, Renton, Richmond, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, St Louis, Stony Brook, St. Petersburg, Sylvania, Syracuse, Tacoma, Tampa, The Bronx, Toledo, Torrance, Traverse City, Troy, Tucson, Tulsa, Washington D.C., West Palm Beach, Wilmington, Winston-Salem, Wyoming, Yakima
- Age
- 1 year to 30 years
- People
- 461 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04546399 - Phase 1/2Taking peopleTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Where
- Charlotte, Hershey, Houston, Little Rock, Los Angeles, Madera, Minneapolis, New York, Norfolk, Orange, Orlando, Palo Alto, Phoenix, Portland, Salt Lake City, San Antonio, San Diego
- Age
- Up to 1 year
- People
- 90 worldwide
- Run by
- Tanja Andrea Gruber
See details and how to joinNCT05848687 - Phase 3Taking peopleA Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
- Where
- Cincinnati, Houston, Memphis, New York, Philadelphia
- Age
- 1 year to 64 years
- People
- 130 worldwide
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07223021 · EU 2025-523096-34-00 - Phase 1Not yet taking people in United StatesA Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07283640 - Phase 2Taking peopleBlinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 90
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03263572 - Phase 1/2Taking peoplePhase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Where
- Houston, The Bronx
- Age
- 18 years and over
- People
- 40
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06308588 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Ann Arbor, Cincinnati, Dallas, Houston, Milwaukee, New York, Portland, Salt Lake City, St Louis
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Not yet taking people in United StatesA Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
- Where
- New York
- Age
- 18 years to 55 years
- People
- 26
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT07313852 - Phase 1Taking peopleAzacitidine and Abatacept in Relapsed or Refractory T-Cell Lymphoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 20
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07388563 - Phase 2Not yet taking people in United StatesObesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma
- Where
- Memphis
- Age
- 12 years to 24 years
- People
- 100
- Run by
- St. Jude Children's Research Hospital
See details and how to joinNCT07790913 - Phase 1Not yet taking people in United StatesBLinatumomab and iNKT in Relapsed B-Cell ALL
- Where
- Chapel Hill
- Age
- 18 years and over
- People
- 13
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT07869368 - Phase 1Taking peoplePhase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- Where
- Bethesda
- Age
- 3 years to 35 years
- People
- 54
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT02390752 - Phase 3Taking peopleInotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Where
- Aberdeen, ‘Aiea, Aitkin, Albuquerque, Allentown, Alton, American Fork, Anaconda, Anchorage, Ann Arbor, Antioch, Arroyo Grande, Ashland, Atlanta, Augusta, Aurora, Baker City, Ballwin, Baltimore, Baton Rouge, Battle Creek, Bellevue, Bellingham, Bend, Bethlehem, Billings, Birmingham, Boiling Springs, Boise, Bolivar, Boston, Boulder, Bozeman, Brainerd, Branson, Brighton, Buffalo, Burbank, Burnsville, Burr Ridge, Butte, Caldwell, Cambridge, Canton, Caro, Carroll, Carson City, Cedar City, Centennial, Centralia, Chapel Hill, Chelsea, Cheyenne, Chicago, Cincinnati, City of Saint Peters, Clackamas, Clarkston, Cleveland, Clinton, Clovis, Cody, Coeur d'Alene, Columbia, Columbus, Coon Rapids, Coos Bay, Costa Mesa, Creve Coeur, Deer River, Denver, Des Moines, Detroit, Detroit Lakes, Dublin, Duluth, Durham, Easley, East China Township, East Stroudsburg, Edina, Edmonds, Emmett, Englewood, Evanston, Everett, Fairbanks, Fairfax, Falls Church, Fargo, Farmington Hills, Fergus Falls, Flint, Fort Dodge, Fort Lauderdale, Fort Smith, Fosston, Fremont, Fresno, Fridley, Fruitland, Garden City, Glenview, Golden, Grand Junction, Grand Rapids, Great Bend, Great Falls, Greeley, Greenville, Greer, Grosse Pointe Woods, Hartford, Hayward, Hazleton, Henderson, Hibbing, Highland Park, Hilo, Hollywood, Homer Glen, Honolulu, Houston, Iowa City, Irvine, Issaquah, Jamestown, Joplin, Kalamazoo, Kalispell, Kansas City, Kennewick, Kingman, Lacey, Lafayette, Lake Forest, Lake Success, Lakewood, Lansing, Las Vegas, Lawrence, Lexington, Lihue, Lisle, Littleton, Livonia, Logan, Lone Tree, Longview, Loveland, Lubbock, Macomb, Madison, Manhasset, Maple Grove, Maplewood, Marlette, Marshfield, Maywood, Melrose Park, Meridian, Miami, Milwaukee, Minneapolis, Missoula, Modesto, Monticello, Mount Vernon, Murray, Muskegon, Nampa, Newberg, New Haven, New Hyde Park, New Lenox, New Orleans, New Richmond, New Ulm, New York, Niles, Norton Shores, Oakland, Ogden, Oklahoma City, Omaha, Ontario, Orange, Orlando, Orland Park, Pahrump, Palo Alto, Park Rapids, Pembroke Pines, Philadelphia, Phoenix, Pittsburgh, Pontiac, Portland, Port Townsend, Post Falls, Princeton, Providence, Provo, Rancho Cordova, Redmond, Redwood City, Reed City, Reno, Renton, Richmond, Riverton, Robbinsdale, Rochester, Rochester Hills, Rohnert Park, Rolla, Roseville, Sacramento, Saginaw, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Sandstone, San Francisco, San Jose, San Leandro, San Rafael, Santa Clara, Santa Rosa, Scottsdale, Seattle, Sedro-Woolley, Seneca, Shakopee, Shelton, Sheridan, South San Francisco, Spooner, Springfield, Sterling Heights, St. George, Stillwater, St Louis, Stockton, Stony Brook, Superior, Syracuse, Tawas City, Thornton, Traverse City, Twin Falls, Vacaville, Vallejo, Vancouver, Verona, Virginia, Waconia, Walla Walla, Walnut Creek, Warren, Washington, West Branch, West Chester, West Des Moines, Westwood, Wheat Ridge, Wichita, Willmar, Winston-Salem, Woodbury, Wyoming, Yakima, Yelm, Ypsilanti
- Age
- 18 years to 39 years
- People
- 303 worldwide
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT03150693 - Phase 1Taking peopleAsciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Where
- Duarte
- Age
- 18 years and over
- People
- 30
- Run by
- City of Hope Medical Center
See details and how to joinNCT07040982 - Phase 1Not yet taking people in United StatesAsciminib-Based Induction Therapy for the Treatment of Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Where
- Duarte
- Age
- 18 years and over
- People
- 21
- Run by
- City of Hope Medical Center
See details and how to joinNCT07914166 - Phase 2Taking peoplePersonalized NK Cell Therapy in CBT
- Where
- Houston
- Age
- 15 years to 80 years
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT02727803